We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SDA:NASDAQSunCar Technology Group Inc. Analysis

Data as of 2026-08-31 - not real-time

$0.71

Latest Price

9/10Risk

Risk Level: High

Executive Summary

SunCar Technology Group Inc. is priced at $0.7130 and its moving averages line up in bearish order, the shorter trailing the longer. The last 30 days have lost 12.8%. RSI sits at 43.3, which reads as neutral, and MACD momentum is bearish. Watch $0.6000 as support and $0.8700 as the nearer resistance level.
On valuation the read is undervalued — an earnings multiple of 4.8, absent a reliable peer benchmark. The average analyst target implies 601.3% above today's level. Revenue is growing at 27.9% on a -0.6% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 53.3%, a beta of 0.73 and a maximum drawdown of 81.5%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

1H 2026 Revenue of $271 million to $273 million 1H 2026 Year Over Year Revenue Growth of 22% to 23% Q2 2026 Net Income...1H 2026 Revenue of $271 million to $273 millionNEW YORK, July 30, 2026 GLOBE NEWSWIRE -- SunCar Technology Group Inc.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.46
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 1.46
  • Analyst targets imply +601.3% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative profit margin of -0.6%
  • Analyst targets imply +601.3% versus the current price
  • Revenue growth of +27.9%

Key Metrics & Analysis

Financial Health

Revenue Growth27.90%
Profit Margin-0.55%
P/E Ratio4.8
ROE3.07%
ROA2.30%
Debt/Equity91.78
P/B Ratio2.2
Op. Cash Flow$7.0M
Free Cash Flow$4.0M

Technical Analysis

TrendBearish
RSI43.3
Support$0.60
Resistance$0.87
MA 20$0.75
MA 50$0.79
MA 200$1.46
MACDBearish
VolumeIncreasing
Fear & Greed Index94.79

Valuation

Fair Value$0.86
Target Price$5.00
Upside/Downside601.26%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.73
Volatility53.33%
Sector RiskHigh
Reg. RiskLow
Geo RiskHigh
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.